Webinar on demand
Percorso verso la resilienza durante la pandemia di COVID-19
28 ottobre 2020
· 56 MIN VISIONE
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/sachin-gupta-699x699px.jpg/_jcr_content/renditions/original.image_file.100.100.file/sachin-gupta-699x699px.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/sachin-gupta-699x699px.jpg/_jcr_content/renditions/original.image_file.360.360.file/sachin-gupta-699x699px.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/sachin-gupta-699x699px.jpg/_jcr_content/renditions/original./sachin-gupta-699x699px.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/sachin-gupta-699x699px.jpg/_jcr_content/renditions/original./sachin-gupta-699x699px.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/sachin-gupta-699x699px.jpg/_jcr_content/renditions/original./sachin-gupta-699x699px.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/sachin-gupta-699x699px.jpg/_jcr_content/renditions/original./sachin-gupta-699x699px.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/sachin-gupta-699x699px.jpg/_jcr_content/renditions/original./sachin-gupta-699x699px.jpg"})
Autore
Dr. Sachin Gupta
Fondatore di Salus Healthcare Resources
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/ronald-yeoh-699x699px.jpg/_jcr_content/renditions/original.image_file.100.100.0,1,698,699.file/ronald-yeoh-699x699px.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/ronald-yeoh-699x699px.jpg/_jcr_content/renditions/original.image_file.360.360.0,1,698,699.file/ronald-yeoh-699x699px.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/ronald-yeoh-699x699px.jpg/_jcr_content/renditions/original.image_file.698.698.0,1,698,699.file/ronald-yeoh-699x699px.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/ronald-yeoh-699x699px.jpg/_jcr_content/renditions/original.image_file.698.698.0,1,698,699.file/ronald-yeoh-699x699px.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/ronald-yeoh-699x699px.jpg/_jcr_content/renditions/original.image_file.698.698.0,1,698,699.file/ronald-yeoh-699x699px.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/ronald-yeoh-699x699px.jpg/_jcr_content/renditions/original.image_file.698.698.0,1,698,699.file/ronald-yeoh-699x699px.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/ronald-yeoh-699x699px.jpg/_jcr_content/renditions/original.image_file.698.698.0,1,698,699.file/ronald-yeoh-699x699px.jpg"})
Autore
Dr. R. Yeoh
Co-fondatore e direttore di Eye & Retina Surgeons
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/guan-seng-khoo-699x699px.jpg/_jcr_content/renditions/original.image_file.100.100.file/guan-seng-khoo-699x699px.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/guan-seng-khoo-699x699px.jpg/_jcr_content/renditions/original.image_file.360.360.file/guan-seng-khoo-699x699px.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/guan-seng-khoo-699x699px.jpg/_jcr_content/renditions/original./guan-seng-khoo-699x699px.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/guan-seng-khoo-699x699px.jpg/_jcr_content/renditions/original./guan-seng-khoo-699x699px.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/guan-seng-khoo-699x699px.jpg/_jcr_content/renditions/original./guan-seng-khoo-699x699px.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/guan-seng-khoo-699x699px.jpg/_jcr_content/renditions/original./guan-seng-khoo-699x699px.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/386-roadmap-to-resilience-amid-the-covid-19-pandemic/guan-seng-khoo-699x699px.jpg/_jcr_content/renditions/original./guan-seng-khoo-699x699px.jpg"})
Autore
Dr. G. Seng Khoo
Consulente APAC per Kamakura Corporation
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/379---decision-making-matrix-%E2%80%93-managing-presbyopia/detlev-breyer-699x699px.jpg/_jcr_content/renditions/original.image_file.100.100.file/detlev-breyer-699x699px.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/379---decision-making-matrix-%E2%80%93-managing-presbyopia/detlev-breyer-699x699px.jpg/_jcr_content/renditions/original.image_file.360.360.file/detlev-breyer-699x699px.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/379---decision-making-matrix-%E2%80%93-managing-presbyopia/detlev-breyer-699x699px.jpg/_jcr_content/renditions/original./detlev-breyer-699x699px.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/379---decision-making-matrix-%E2%80%93-managing-presbyopia/detlev-breyer-699x699px.jpg/_jcr_content/renditions/original./detlev-breyer-699x699px.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/379---decision-making-matrix-%E2%80%93-managing-presbyopia/detlev-breyer-699x699px.jpg/_jcr_content/renditions/original./detlev-breyer-699x699px.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/379---decision-making-matrix-%E2%80%93-managing-presbyopia/detlev-breyer-699x699px.jpg/_jcr_content/renditions/original./detlev-breyer-699x699px.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/379---decision-making-matrix-%E2%80%93-managing-presbyopia/detlev-breyer-699x699px.jpg/_jcr_content/renditions/original./detlev-breyer-699x699px.jpg"})
Autore
Dr. D. Breyer
CEO di Breyer, Kaymak e Klabe Eye Surgery Clinic
RIEPILOGO
Sfide nelle attività professionali durante e dopo la pandemia
I nostri relatori provenienti da tutto il mondo si uniscono a noi per una conversazione sugli impatti di questa pandemia sul settore della refrazione, sui nostri pazienti e sui nostri studi. Soprattutto, rispondono alla domanda su cui tutti stiamo riflettendo: Come costruire uno studio che trascenda il tempo?